Skip to main content

MoneyWorks4Me

Shilpa Medicare informs about company updates

04 Oct 2016 Evaluate

Shilpa Medicare has informed that the Company has received an approval from the United States Food & Drug Administration (USPDA) for Azacitidine - Injection Anda of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..